Cohance Lifesciences Grants 172,570 Stock Options, Allots 25,600 Shares

Cohance Lifesciences Ltd announced that its Nomination and Remuneration Committee has approved the grant of 69,028 stock options under ESOP 2026 and 103,542 stock options under ESOP 2023. Additionally, the company has allotted 25,600 equity shares of face value INR 1 each, fully paid-up, to employees who exercised their vested options under ESOP 2023. The ESOP 2026 grants have an exercise price not less than INR 325, with vesting between 1 to 8 years and exercise period up to 3 years post-vesting. The ESOP 2023 details regarding exercise price, vesting, and exercise period are subject to grant letters.